To determine the specificity of VCP as a tumor marker for GCT, serum VCP levels were assessed in patients with ovarian carcinomas, as well as in small cohorts of patients with major non-ovarian cancers of known histology and grade (Table 3). This evidence concerns the gene VCP and ovarian cancer.